These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 469561

  • 1. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO, Halliday D, Purkiss P, Royston P.
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ, Tomas FM, Stern LM.
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [Abstract] [Full Text] [Related]

  • 6. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM, Tomas FM, Ballard FJ.
    Muscle Nerve; 1981 Apr; 4(1):62-6. PubMed ID: 7231447
    [Abstract] [Full Text] [Related]

  • 7. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
    Inoue R, Miyake M, Kanazawa A, Sato M, Kakimoto Y.
    Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Myofibrillar protein catabolism in rat steroid myopathy measured by 3-methylhistidine excretion in the urine.
    Shoji S.
    J Neurol Sci; 1989 Nov; 93(2-3):333-40. PubMed ID: 2592991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 3-Methylhistidine as a measure of skeletal muscle protein breakdown in human subjects: the case for its continued use.
    Ballard FJ, Tomas FM.
    Clin Sci (Lond); 1983 Sep; 65(3):209-15. PubMed ID: 6872455
    [No Abstract] [Full Text] [Related]

  • 12. Immunochemical study of connectin (titin) in neuromuscular diseases using a monoclonal antibody: connectin is degraded extensively in Duchenne muscular dystrophy.
    Matsumura K, Shimizu T, Nonaka I, Mannen T.
    J Neurol Sci; 1989 Nov; 93(2-3):147-56. PubMed ID: 2592979
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
    Röthig HJ, Bernhardt W, Afting EG.
    Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Content of methylhistidines in normal and pathological human skeletal muscles.
    Mussini E, Cornelio F, Dworzak F, Cotellessa L, Morandi L, Colombo L, De Ponte G, Marcucci F.
    Muscle Nerve; 1983 Jun; 6(6):423-9. PubMed ID: 6621612
    [Abstract] [Full Text] [Related]

  • 19. N tau-Methylhistidine excretion and myofibrillar protein breakdown in patients receiving intravenous or enteral nutrition.
    Holbrook IB, Gross E, Milewski PJ, Shipley K, Irving MH.
    Clin Sci (Lond); 1980 Sep; 59(3):211-4. PubMed ID: 6775857
    [Abstract] [Full Text] [Related]

  • 20. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown.
    Rennie MJ, Millward DJ.
    Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.